Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 123

    1.

    Tenascin-C expression in normal, inflamed, and scarred human corneas.

    Maseruka H, Bonshek RE, Tullo AB.

    Br J Ophthalmol. 1997 Aug;81(8):677-82.PMID: 9349157 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea.

    Tuori A, Virtanen I, Aine E, Uusitalo H.

    Graefes Arch Clin Exp Ophthalmol. 1997 Apr;235(4):222-9.PMID: 9143890 [PubMed - indexed for MEDLINE]Related articles

    3.

    Tenascin-cytotactin (TN-C) variants in pseudophakic/aphakic bullous keratopathy corneas.

    Maseruka H, Ataullah SM, Zardi L, Tullo AB, Ridgway AE, Bonshek RE.

    Eye (Lond). 1998;12 ( Pt 4):729-34.PMID: 9850274 [PubMed - indexed for MEDLINE]Related articles

    4.

    Expression of tenascin-C splice variants in normal and bullous keratopathy human corneas.

    Ljubimov AV, Saghizadeh M, Spirin KS, Khin HL, Lewin SL, Zardi L, Bourdon MA, Kenney MC.

    Invest Ophthalmol Vis Sci. 1998 Jun;39(7):1135-42.PMID: 9620072 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.

    Leins A, Riva P, Lindstedt R, Davidoff MS, Mehraein P, Weis S.

    Cancer. 2003 Dec 1;98(11):2430-9.PMID: 14635078 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Ultrastructural morphology and expression of proteoglycans, betaig-h3, tenascin-C, fibrillin-1, and fibronectin in bullous keratopathy.

    Akhtar S, Bron AJ, Hawksworth NR, Bonshek RE, Meek KM.

    Br J Ophthalmol. 2001 Jun;85(6):720-31.PMID: 11371495 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Developmental changes in patterns of expression of tenascin-C variants in the human cornea.

    Maseruka H, Ridgway A, Tullo A, Bonshek R.

    Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4101-7.PMID: 11095602 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Differential expression of collagen types XVIII/endostatin and XV in normal, keratoconus, and scarred human corneas.

    Määttä M, Heljasvaara R, Sormunen R, Pihlajaniemi T, Autio-Harmainen H, Tervo T.

    Cornea. 2006 Apr;25(3):341-9.PMID: 16633037 [PubMed - indexed for MEDLINE]Related articles

    9.

    Expression of wound healing and stress-related proteins in keratoconus corneas.

    Zhou L, Yue BY, Twining SS, Sugar J, Feder RS.

    Curr Eye Res. 1996 Nov;15(11):1124-31.PMID: 8950507 [PubMed - indexed for MEDLINE]Related articles

    10.

    Increased expression of tenascin-C-binding epithelial integrins in human bullous keratopathy corneas.

    Ljubimov AV, Saghizadeh M, Pytela R, Sheppard D, Kenney MC.

    J Histochem Cytochem. 2001 Nov;49(11):1341-50.PMID: 11668187 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Immunohistochemical detection of betaIG-H3 in scarring human corneas.

    Takács L, Csutak A, Balázs E, Berta A.

    Graefes Arch Clin Exp Ophthalmol. 1999 Jul;237(7):529-34.PMID: 10424302 [PubMed - indexed for MEDLINE]Related articles

    12.

    Extracellular matrix and matrix metalloproteinase changes in human corneas after complicated laser-assisted in situ keratomileusis (LASIK).

    Maguen E, Zorapapel NC, Zieske JD, Ninomiya Y, Sado Y, Kenney MC, Ljubimov AV.

    Cornea. 2002 Jan;21(1):95-100.PMID: 11805516 [PubMed - indexed for MEDLINE]Related articles

    13.

    Lectin binding in normal, scarred, and keratoconus corneas.

    Tuori A, Virtanen I, Uusitalo R, Uusitalo H.

    Cornea. 1998 Jan;17(1):88-98.PMID: 9436886 [PubMed - indexed for MEDLINE]Related articles

    14.

    Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta (TGF-beta) modulate tenascin-C and fibrillin-1 in bullous keratopathy stromal cells in vitro.

    Kenney MC, Zorapapel N, Atilano S, Chwa M, Ljubimov A, Brown D.

    Exp Eye Res. 2003 Nov;77(5):537-46.PMID: 14550395 [PubMed - indexed for MEDLINE]Related articles

    15.

    Corneal wound healing in tenascin knockout mouse.

    Matsuda A, Yoshiki A, Tagawa Y, Matsuda H, Kusakabe M.

    Invest Ophthalmol Vis Sci. 1999 May;40(6):1071-80.PMID: 10235540 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier.

    Ambati BK, Patterson E, Jani P, Jenkins C, Higgins E, Singh N, Suthar T, Vira N, Smith K, Caldwell R.

    Br J Ophthalmol. 2007 Apr;91(4):505-8. Epub 2006 Dec 6. Erratum in: Br J Ophthalmol. 2008 Mar;92(3):441-2. PMID: 17151056 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Expression and significance of human leukocyte antigen DR and intercellular adhesion molecule-1 in normal and pathological corneas]

    Gu Y, Wang J.

    Zhonghua Yan Ke Za Zhi. 1999 Sep;35(5):376-9, 20. Chinese. PMID: 11835844 [PubMed - indexed for MEDLINE]Related articles

    18.

    Diagnostic utility of tenascin-C for evaluation of the activity of human acute myocarditis.

    Morimoto S, Imanaka-Yoshida K, Hiramitsu S, Kato S, Ohtsuki M, Uemura A, Kato Y, Nishikawa T, Toyozaki T, Hishida H, Yoshida T, Hiroe M.

    J Pathol. 2005 Mar;205(4):460-7.PMID: 15685595 [PubMed - indexed for MEDLINE]Related articles

    19.

    Novel splice variants of human tenascin-C mRNA identified in normal and bullous keratopathy corneas.

    Saghizadeh M, Khin HL, Bourdon MA, Kenney MC, Ljubimov AV.

    Cornea. 1998 May;17(3):326-32.PMID: 9603390 [PubMed - indexed for MEDLINE]Related articles

    20.

    Extracellular matrix alterations in human corneas with bullous keratopathy.

    Ljubimov AV, Burgeson RE, Butkowski RJ, Couchman JR, Wu RR, Ninomiya Y, Sado Y, Maguen E, Nesburn AB, Kenney MC.

    Invest Ophthalmol Vis Sci. 1996 May;37(6):997-1007.PMID: 8631643 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data